Skip to main content

Developmental Immunotoxicity (DIT): The Why, When, and How of DIT Testing

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 598))

Abstract

Developmental immunotoxicity (DIT) has emerged as a serious health consideration given the increases in the prevalence of many immune-based childhood diseases and conditions, including allergic diseases and asthma, recurrent otitis media, pediatric celiac disease, and type 1 diabetes. As a result, the use of DIT testing to identify potential environmental risk factors contributing to these and other diseases has become a higher priority. This introductory chapter considers: (1) the basis for an increased and earlier use of DIT testing in safety evaluations and (2) the general features of DIT testing strategies designed to reduce health risks.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Luster MI, Faith RE, Kimmel CA (1978) Depression of humoral immunity in rats following chronic developmental lead exposure. J Toxicol Environ Pathol 1:397–402

    CAS  Google Scholar 

  2. Barnett JB, Holcomb D, Menna JH, Soderberg LS (1985) The effect of prenatal chlordane exposure on specific anti-influenza cell-mediated immunity. Toxicol Lett 25:229–238

    Article  CAS  PubMed  Google Scholar 

  3. Dietert RR, Qureshi MA, Nanna UC, Bloom SE (1985) Embryonic exposure to aflatoxin-B1: mutagenicity and influence on development and immunity. Environ Mutagen 7:715–725

    Article  CAS  PubMed  Google Scholar 

  4. Holladay SD (2005) Developmental immunotoxicology. CRC Press, Boca Raton, FL

    Google Scholar 

  5. Barnett JB (1996) Developmental immunotoxicology. In: Smialowicz RJ, Holsapple MP (eds) Experimental Immunotoxicology. CRC Press, Boca Raton, FL, pp 47–62

    Google Scholar 

  6. Smialowicz RJ, Brundage KB, Barnett JB (2007) Immune system ontogeny and developmental immunotoxicology. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and Immunopharmacology, 3rd edn. CRC Press, Boca Raton, FL, pp 327–346

    Google Scholar 

  7. Dietert RR (2009) Developmental immunotoxicology. In: Ballantyne B, Marrs T, Syversen T (eds) General and applied toxicology, 3rd edn. Wiley, Chichester, UK, pp 1977–1991

    Google Scholar 

  8. Dietert RR, Burns-Naas LA (2008) Develop­mental immunotoxicity in rodents. In: Herzyk DJ, Bussiere JL (eds) Immunotoxicology strategies for pharmaceutical safety assessment. Wiley, Hoboken, NJ, pp 273–297

    Google Scholar 

  9. Holsapple MP, van der Laan JW, van Loveren H (2008) Development of a framework for developmental immunotoxicity (DIT) testing. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and Immunopharma­cology, 3rd edn. CRC Press, Boca Raton, FL, pp 327–346

    Google Scholar 

  10. Luster MI, Dietert RR, Germolec DR, Luebke RW, Makris SL (2008) Developmental immunotoxicology. In: Sonawane B, Brown R (eds) Encyclopedia of environmental health. Elsevier, Oxford

    Google Scholar 

  11. Dietert RR, Piepenbrink MS (2006) Perinatal immunotoxicity: why adult exposure assessment fails to predict risk. Environ Health Perspect 114:477–483

    Article  CAS  PubMed  Google Scholar 

  12. Lu YC, Wu YC (1985) Clinical findings and immunological abnormalities in Yu-Cheng patients. Environ Health Perspect 59:17–29

    Article  CAS  PubMed  Google Scholar 

  13. Nakanishi Y, Shigematsu N, Kurita Y, Matsuba K, Kanegae H, Ishimaru S, Kawazoe Y (1985) Respiratory involvement and immune status in Yusho patients. Environ Health Perspect 59:31–36

    Article  CAS  PubMed  Google Scholar 

  14. Yu ML, Hsin JW, Hsu CC, Chan WC, Guo YL (1998) The immunologic evaluation of the Yucheng children. Chemosphere 37:1855–1865

    Article  CAS  PubMed  Google Scholar 

  15. Dewailly E, Ayotte P, Bruneau S, Gingras S, Belles-Isles M, Roy R (2001) Susceptibility to infections and immune status in Inuit infants exposed to organochlorines. Environ Health Perspect 108:205–211

    Google Scholar 

  16. Weisglas-Kuperus N, Patandin S, Berbers GA, Sas TC, Mulder PG, Sauer PJ, Hooijkaas H (2000) Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect 108:1203–1207

    CAS  PubMed  Google Scholar 

  17. Karmaus W, Kuehr J, Kruse H (2001) Infections and atopic disorders in childhood and organochlorine exposure. Arch Environ Health 56:485–492

    Article  CAS  PubMed  Google Scholar 

  18. Luebke RW, Chen DH, Dietert R, Yang Y, King M, Luster MI (2006) The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B Crit Rev 9:1–26

    Article  CAS  PubMed  Google Scholar 

  19. Dietert RR, Lee JE, Bunn TL (2002) Developmental immunotoxicology: emerging issues. Hum Exp Toxicol 21:479–485

    Article  CAS  PubMed  Google Scholar 

  20. Selevan SG, Kinnel CA, Mendola P (2000) Identifying critical windows of exposure for children’s health. Environ Health Perspect 108(Suppl. 3):451–455

    Article  PubMed  Google Scholar 

  21. Daston G, Faustman E, Ginsberg G, Fenner-Crisp P, Olin S, Sonanwane B, Bruckner J, Breslin W, McLaughlin TJ (2004) A framework for assessing risks to children from exposure to environmental agents. Environ Health Perspect 112:238–256

    Article  CAS  PubMed  Google Scholar 

  22. Landrigan PJ, Kimmel CA, Correa A, Eskenazi B (2004) Children’s health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect 112:257–265

    Article  CAS  PubMed  Google Scholar 

  23. Kimmel CA, Collman GW, Fields N, Eskenzi B (2005) Lessons learned for the National Children’s Study from the National Institute of Environmental Health Sciences/U.S. Environmental Protection Agency Centers for Children’s Environmental Health and Disease Prevention Research. Environ Health Perspect 113:1414–1418

    Article  CAS  PubMed  Google Scholar 

  24. Landrigan PJ, Trasande L, Thorpe LE, Gwynee C, Lioy PJ, D’Alton ME, Lipkind HS, Swanson J, Wadhwa PD, Clark EB, Rauh VA, Perera FP, Susser E (2006) The National Children’s Study: a 21-year prospective study of 100, 000 American children. Pediatrics 118:2173–2186

    Article  PubMed  Google Scholar 

  25. World Health Organization. International Programme on Chemical Safety (2006) Principles for evaluating health risks in ­children associated with exposure to chemicals. WHO Publications, Geneva

    Google Scholar 

  26. Dietert RR (2008) Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk. Curr Drug Saf 3:216–226

    Article  PubMed  Google Scholar 

  27. Holladay SD, Smialowicz RJ (2000) Develop­ment of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environ Health Perspect 108(Suppl. 3):463–473

    Article  CAS  PubMed  Google Scholar 

  28. Dietert RR, Etzel RA, Chen D, Halonen M, Holladay SD, Jarabek AM, Landreth K, Peden DB, Pinkerton K, Smialowicz RJ, Zoetis T (2000) Workshop to identify critical windows of exposure for children’s health: immune and respiratory systems work group summary. Environ Health Perspect 108(Suppl. 3):483–490

    Article  PubMed  Google Scholar 

  29. Luster MI, Dean JH, Germolec DR (2003) Consensus workshop on methods to evaluate developmental immunotoxicity. Environ Health Perspect 111:579–583

    Article  CAS  PubMed  Google Scholar 

  30. Holsapple MP, Paustenbach DJ, Charnley G, West LJ, Luster MI, Dietert RR, Burns-Naas L (2004) Symposium summary: children’s health risk-What’s so special about the developing immune system? Toxicol Appl Pharmacol 199:61–70

    Article  CAS  PubMed  Google Scholar 

  31. Luster MI, Johnson VJ, Yucesoy B, Simeonova PP (2005) Biomarkers to assess potential developmental immunotoxicity in children. Toxicol Appl Pharmacol 206:229–236

    Article  CAS  PubMed  Google Scholar 

  32. Dietert RR, Holsapple M (2007) Methodo­logies for developmental immunotoxicity (DIT) testing. Methods. 41:123–131

    Article  CAS  PubMed  Google Scholar 

  33. Selgrade MK (2007) Immunotoxicity: the risk is real. Toxicol Sci 100:328–332

    Article  CAS  PubMed  Google Scholar 

  34. Burns-Naas LA, Hastings KL, Ladics GS, Makris SL, Parker GA, Holsapple MP (2008) What’s so special about the developing immune system? Int J Toxicol 27:223–254

    Article  PubMed  Google Scholar 

  35. Dietert RR (2009) Developmental immunotoxicology: focus on health risks. Chem Res Toxicol 22(1):17–23

    Article  CAS  PubMed  Google Scholar 

  36. Dietert RR, Zelikoff JT (2008) Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma. Birth Defects Res B Develop Reprod Toxicol 83(6):547–560

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Janice Dietert for her editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rodney R. Dietert .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Dietert, R.R., DeWitt, J. (2010). Developmental Immunotoxicity (DIT): The Why, When, and How of DIT Testing. In: Dietert, R. (eds) Immunotoxicity Testing. Methods in Molecular Biology™, vol 598. Humana Press. https://doi.org/10.1007/978-1-60761-401-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-401-2_2

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-400-5

  • Online ISBN: 978-1-60761-401-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics